Regimen Design and Dosing for Children with Drug-Resistant TB: A Case-Based Discussion by Dr. Jennifer Furin and Dr. James Seddon
Friday, April 25, 2014 9:00:00 AM EDT - 10:00:00 AM EDT
This webinar will review the case of a child with DR-TB and focus on the following topics:
1) A review of key principles for regimen construction in children with DR-TB;
2) A presentation of the latest dosing recommendations and PK data on second-line drugs in children; and
3) A discussion on the use of new TB drugs and regimens in children with DR-TB.
Register for the event using this link:
If you have any questions about registering or connecting for this webinar, please contact Ms. Evgenia Markvardt at
Dr. Jennifer Furin is an infectious disease physician and anthropologist who has dedicated her career to providing health care for the sick and poor around the world. She received her PhD in medical anthropology from UCLA in 1995 and her MD from Harvard Medical School in 1999. She has implemented programs for patients with HIV and TB in resource-poor settings, including Haiti, Peru, Russia, Boston, South Africa and Lesotho. Dr. Furin has worked with patients who have MDR-TB since 1995 and has treated hundreds of children with the disease. She currently leads the Capacity Building Task Force at the Sentinel Project on Pediatric Drug-Resistant Tuberculosis and serves as a regular consultant and strong advocate for children and families affected by this disease.
Dr. James Seddon is an Academic Clinical Lecturer in Paediatric Infectious Diseases at Imperial College London. His major area of research is that of children with tuberculosis, specifically drug-resistant forms. He studied medicine at Corpus Christi College, Cambridge and Imperial College London and has carried out paediatric training in both UK and Australia. Before clinical academia, he was an infantry officer in the British army, worked as a doctor for Médecins Sans Frontières in Côte d'Ivoire and spent time on an expedition in Patagonia. Most recently he has been in Cape Town, completing a PhD. Along the way he has studied for Diplomas in Tropical Medicine and Paediatric Infectious Diseases.
The Sentinel Project on Pediatric Drug-Resistant Tuberculosis is a global partnership of researchers, caregivers, and advocates who share a vision of a world where no child dies from this curable disease. We are collaborating to raise the visibility of this vulnerable population of children, and to share evidence and resources that can increase children’s access to prompt and effective treatment. For more information and to join this network, please visit us at www.sentinel-project.org